Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameTick-Borne Disease Working GroupAgency NameDepartment of Health and Human Services
Fiscal Year2019Committee Number2619
Original Establishment Date8/10/2017Committee StatusChartered
Actual Termination Date Committee URLhttps://www.hhs.gov/ash/advisory-committees/tic...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*14
Current Charter Date8/10/2019Designated Fed Officer Position Title*Senior Advisor for Blood and Tissue Policy, Office of HIV/AIDS and Infectious Disease Policy
Date Of Renewal Charter8/10/2021Designated Federal Officer Prefix
Projected Termination Date12/13/2022Designated Federal Officer First Name*James
Exempt From Renewal*NoDesignated Federal Officer Middle NameJ
Specific Termination AuthoritySection 2062 of the 21st Century Cures ActDesignated Federal Officer Last Name*Berger
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixM.S., M.T.(ASCP), S.B.B.
Specific Establishment Authority*Section 2062 of the 21st Century Cures ActDesignated Federal Officer Phone*202 795-7608
Effective Date Of Authority*12/13/2016Designated Federal Officer Fax*202 692-2101
Committee Type*ContinuingDesignated Federal Officer Email*james.berger@hhs.gov
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNo
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The 21st Century Cures Act (Public Law 114-255) was enacted to advance the research and development of new therapies and diagnostics and make substantial federal investments in a wide range of health priorities. The Department of Health and Human Services has responsibility for ensuring the conduct of and support for epidemiological, basic, translational, and clinical research related to vector-borne diseases, including tick-borne diseases. Under Section 2062 of the 21st Century Cures Act, the Secretary of Health and Human Services is mandated to establish the Tick-Borne Disease Working Group. The Working Group assists HHS in its effort to properly address this important public health concern. The Working Group will provide expertise and review all activities being undertaken by HHS that pertain to tick-borne diseases. It is stipulated in the authorizing legislation and the committee charter that the Working Group will develop or update a summary of ongoing activities, including research, related to tick-borne diseases that are being undertaken by HHS and other federal agencies and offices; make recommendations to the Secretary regarding any appropriate changes or improvements to such activities and research; and solicit input from States, localities, and non-government entities. Two years after enactment of P.L. 114-255, the Working Group is required to submit a report that contains its findings and recommendations to the Secretary and the appropriate Congressional committees.
How is membership balanced?*The Working Group is authorized to have 14 members. The membership will represent a diversity of scientific disciplines and views from the appropriate federal agencies and non-federal entities. The composition of the Working Group consists of seven federal members and seven non-federal public members. Individuals who are selected to serve as non-federal public members may represent the following categories: physicians and other health care providers with experience in diagnosing and treating tick-borne diseases; scientists or researchers with expertise; patients and their family members; and members of nonprofit organizations that advocate for patients with respect to tick-borne diseases. The federal member category will consist of one or more representatives from the following HHS organizational components: Office of the Assistant Secretary for Health, Centers for Disease Prevention and Control, Food and Drug Administration, and the National Institutes of Health. Invitations of membership may be extended to other agencies and offices of the Department of Health and Human Services and other individuals as determined by the Secretary to be appropriate and beneficial to the functioning of the Working Group. The Secretary identified that the additional federal members will be from the Centers of Medicare and Medicaid Services, White House, Office of Management and Budget, and the Department of Defense.
How frequent & relevant are cmte mtgs?*It is stipulated in the charter that the Working Group will meet not less than two times a year. The Working Group will discuss topics and issues that are pertinent to its mission during these meetings. The Working Group's deliberations during the meetings will be critical for developing the annual report that must be submitted to the Secretary and the designated Congressional committees to comply with the authorizing statute.
Why advice can't be obtained elsewhere?*The Tick-Borne Disease Working Group is a non-discretionary federal advisory committee. Establishment of the Working Group was statutorily mandated by Congress. The mandate to establish the Working Group can be found in the 21st Century Cures Act (Public Law 114-255) under Section 2062. This legislation was enacted to advance the research and development of new therapies and diagnostics and make substantial federal investments in a wide range of health priorities. The statute stipulates that the Working Group is to be comprised of representatives of appropriate federal agencies and non-federal entities to help ensure that there is a diversity of scientific disciplines and views to provide input on the efforts being undertaken by HHS to properly address the issues and concerns regarding the conduct and support research on vector-borne diseases, including tick-borne diseases. The diversity of the membership helps to ensure interagency coordination and minimize overlap, and to examine research priorities.
Why close or partially close meetings?All meetings of the Working Group will be open to the public unless it is determined that the topics to be discussed are confidential and sensitive in nature.
Recommendation RemarksThe Working Group convened for its first meeting on December 11, 2017, and has had six subsequent meetings. Two years after enactment of P.L. 114-255, the Working Group is required to submit a report that contains its findings and recommendations to the Secretary and the appropriate Congressional committees. This report is expected to be delivered to Congress in November 2018.

In the meetings section of this report, two different meetings were held on consecutive days (12/11/17 and 12/12/17) and advertised in the Federal Register as such.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentNot applicable
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentCost savings dependent on action taken on recommendationsGrants Review CommentNot Applicable
Number Of Recommendations*28Access Contact Designated Fed. Officer*Yes
Number Of Recommendations Comment28 recommendations will be published in the 2018 Report to Congress.Access Agency WebsiteNo
% of Recs Fully Implemented*0.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentThe 2018 report has not yet been sent to Congress.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentThe 2018 report has not yet been sent to Congress.Access OtherNo
Agency Feedback*NoAccess CommentN/A
Agency Feedback CommentThe 2018 report has not yet been sent to agency for review.Narrative Description*The 21st Century Cures Act (Public Law 114-255) was enacted to advance the research and development of new therapies and diagnostics and make substantial federal investments in a wide range of health priorities. The Department of Health and Human Services has responsibility for ensuring the conduct of and support for epidemiological, basic, translational, and clinical research related to vector-borne diseases, including tick-borne diseases. Under Section 2062 of the 21st Century Cures Act, the Secretary of Health and Human Services is mandated to establish the Tick-Borne Disease Working Group. The Working Group will assist HHS in its effort to properly address this important public health concern. The Working Group will provide expertise and review all activities being undertaken by HHS that pertain to tick-borne diseases. It is stipulated in the authorizing legislation and the committee charter that the Working Group will develop or update a summary of ongoing activities, including research, related to tick-borne diseases that are being undertaken by HHS and other federal agencies and offices; make recommendations to the Secretary regarding any appropriate changes or improvements to such activities and research; and solicit input from States, localities, and non-government entities. Two years after enactment of P.L. 114-255, the Working Group is required to submit a report that contains its findings and recommendations to the Secretary and the appropriate Congressional committees.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members* Est Payments to Non-Fed Members Next FY* 
Payments to Federal Members* Est. Payments to Fed Members Next FY* 
Payments to Federal Staff* Estimated Payments to Federal Staff* 
Payments to Consultants* Est. Payments to Consultants Next FY* 
Travel Reimb. For Non-Federal Members* Est Travel Reimb Non-Fed Members nextFY* 
Travel Reimb. For Federal Members* Est Travel Reimb For Fed Members* 
Travel Reimb. For Federal Staff* Est. Travel Reimb to Fed Staff Next FY* 
Travel Reimb. For Consultants* Est Travel Reimb to Consultants Next FY* 
Other Costs Est. Other Costs Next FY* 
Total Costs$0.00Est. Total Next FY*$0.00
Federal Staff Support (FTE)* Est. Fed Staff Support Next FY* 
Hide Section - Custom Links

Custom Links

     Committee Level Reports               
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - SUBCOMMITTEES

SUBCOMMITTEES

Committee

Subcommittees

ActionCommittee System IDSubcommittee NameFiscal Year
 COM-032454Access to Care Services and Support to Patients2019
 COM-032148Disease Vectors, Surveillance, and Prevention2019
 COM-029674Other Tick-Borne Diseases and Co-Infections2019
 COM-031470Pathogenesis, Transmission and Treatment2019
 COM-030487Testing and Diagnostics2019
 COM-031524Vaccine and Therapeutics2019
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-002040Tick-Borne Disease Working Group2017
 COM-034905Tick-Borne Disease Working Group2018